Immune alveolitis profile in bronchoalveolar lavage of infiltrative lung diseases: not just counting matters.

A. Moui (Nantes, France), S. Dirou (Nantes, France), C. Sagan (Nantes, France), R. Liberge (Nantes, France), C. Defrance (Nantes, France), P. Arrigoni (Nantes, France), O. Morla (Nantes, France), C. Kandel-Aznar (Nantes, France), A. Tissot (Nantes, France), E. Eschapasse (Nantes, France), T. Goronflot (Nantes, France), A. Magnan (Nantes, France), F. Blanc (Nantes, France)

Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Moui (Nantes, France), S. Dirou (Nantes, France), C. Sagan (Nantes, France), R. Liberge (Nantes, France), C. Defrance (Nantes, France), P. Arrigoni (Nantes, France), O. Morla (Nantes, France), C. Kandel-Aznar (Nantes, France), A. Tissot (Nantes, France), E. Eschapasse (Nantes, France), T. Goronflot (Nantes, France), A. Magnan (Nantes, France), F. Blanc (Nantes, France). Immune alveolitis profile in bronchoalveolar lavage of infiltrative lung diseases: not just counting matters.. 3531

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014

Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010

Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014


Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011



Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006


The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases
Source: Eur Respir Mon; 2009: 46: 36–46
Year: 2009

The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
Source: Eur Respir Rev 2010 19: 237-241
Year: 2010



Bronchoalveolar lavage (BAL) in the differential diagnosis of sarcoidosis, extrinsic allergic alveolitis and BOOP
Source: Eur Respir J 2003; 22: Suppl. 45, 255s
Year: 2003

What does bronchoalveolar lavage add to cryobiopsy in interstitial lung disease?
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018

Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014

Biochemical features of bronchoalveolar lavage cells and fluid in different phases of allergic alveolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Interstitial lung disease profiling by mean of broncho-alveolar lavage
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


Cytokine profile in bronchoalveolar lavage fluid of fibrotic idiopathic intersticial pneumonias compared to fibrotic intersticial pneumonias in connective tissue diseases
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Bronchoalveolar lavage cytokine profile in patients with Pulmonary Langerhans Cell Histiocytosis differs from other interstitial lung diseases
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020




Eosinophilic lung disease
Source: International Congress 2016 – Orphan diseases I
Year: 2016


Comparison of cellular composition of induced sputum, bronchial washing and bronchoalveolar lavage fluid in some interstitial lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002

Induced sputum in nonsarcoid interstitial lung diseases; comparison with bronchial wash and BAL
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008